Markers of Treatment Response to Methotrexate in Rheumatoid Arthritis: Where Do We Stand?

Methotrexate (MTX) is the most commonly used disease-modifying antirheumatic drug (DMARD) for the treatment of rheumatoid arthritis (RA). However, despite its efficacy and affordability, additional DMARDs or biologic agents are often required in order to achieve the recommended goals of low disease...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Halilova, Karina I., Brown, Elizabeth E., Morgan, Sarah L., Bridges, S. Louis, Hwang, Min-Ho, Arnett, Donna K., Danila, Maria I.
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2012
Matèries:
Review Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3400362/
https://ncbi.nlm.nih.gov/pubmed/22844292
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/978396
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars